Skip to main content
Top of the Page
Home
News
Toggle
Newsletters
News Archive
About EFSPI
Toggle
Who is EFSPI
EFSPI History
Toggle
Past Presidents
EFSPI Council
Toggle
Officers
Council Members
Member Groups
Working Groups
Executive Office
Constitution
Statistics Leaders Meetings
Toggle
Past Meetings
Toggle
15th Meeting - June 2024
14th Meeting - May 2023
13th Meeting - July 2022
12th Meeting - July 2021
11th Meeting - July 2020
10th Meeting - July 2019
9th Meeting - July 2018
8th Meeting - July 2017
7th Meeting - July 2016
6th Meeting - July 2015
5th Meeting - June 2014
4th Meeting - June 2013
3rd Meeting - June 2012
2nd Meeting - June 2011
1st Meeting - May 2010
SIGS
Publications
Toggle
Annual Reports
Strategy of EFSPI
Toggle
Visibility Working Party
Position Papers
Regulatory Comments
EFSPI Goals
Events
Toggle
Calendar of Events
Meetings
Annual Regulatory Statistics Workshops
Toggle
Next Meeting
Past Meetings
Webinars
Past Events
Activities
Toggle
Member Group Events
Member Group Training
EMA Workshops
The World of Statistics
Links
Advertisements
Toggle
Job Postings
Services
Products
Contact Us
Members
Toggle
Archive
SIGs
Toggle
SIG Resources
AIMS SIG
Benefit-Risk SIG
Biomarkers SIG
Data Transparency
Decision Making SIG
Estimands in Oncology Applications SIG
Health Technology Assessment (HTA) SIG
Historical Data
Medical Devices SIG
New Starters
Small Populations SIG
Subgroup Analysis
Toxicology SIG
Vaccines
Benefit-Risk SIG
Health Technology Assessment (HTA) SIG
Working Groups
Home
News
About EFSPI
Statistics Leaders Meetings
SIGS
Publications
Events
Activities
Links
Advertisements
Contact Us
Members
Past Events
07/03/2022
Recent advances in Clinical Trials
07/03/2022
Small populations and level of evidence
22/11/2019
Reproducibility in Clinical Research
04/06/2019
Precision medicine in drug development
20/03/2019
Recent Developments in Biomarkers and Subgroups
15/02/2019
Latest Trends in Health Technology Assessments (HTA)
17/12/2018
Decision-making in drug development
17/11/2017
European Statistical Meeting Oncology and Survival Analysis
23/06/2017
European Statistical Meeting on Analysis of Safety Data
22/11/2016
European Statistical Meeting on Evidence Synthesis
Brussels, Belgium
04/10/2016
Best Practice in Modelling and Simulation
Together with the Special Interest Group on M&S, EFSPI is organising a Webinar on Best Practice in Modelling and Simulation
24/06/2016
Biomarkers and Subgroups
Netherlands | June 2016
12/11/2015
European Statistical Meeting - Dose Selection in Late Phase Clinical Development
Thursday 12th November 2015 | Belgium
23/06/2015
Application of Methods for Health Technology Assessment
Joint EFSPI / BBS Meeting | June 2015, Basel
01/11/2014
Joint BBS-EFSPI Seminar on Data Sharing in Clinical Development
November 13th 2014 | For Slides follow the link:
www.ceb-institute.org/bbs/
01/09/2014
Generating Evidence for Health Technology Assessment
01/11/2013
Survival Analysis and it's Applications in Drug Development
17/09/2013
Meeting Report
EFSPI/PSI Structured Benefit-Risk 17th September 2013
01/09/2013
EFSPI/PSI - Structured Benefit-Risk Assessment
September 2013 | London
01/08/2013
EFSPI/PSI - EMA Clinical Trial Data Transparancy - August 2013
05/06/2013
Health Technology Assessment - Joint BBS/EFSPI Seminar Programme
On June 4th 2013, the EFSPI and BBS organized a one day meeting on Health Technology Assessment. Over 115 attendees with various backgrounds attended this meeting.
04/06/2013
HTA/Joint BBS/EFSPI Seminar
30/11/2012
European Statistical Meeting on Subgroup Analysis
Friday 30th November 2012, Brussels - Subgroups analyses are important for a comprehensive assessment of confirmatory trials in marketing authorisation application. Indeed, the CHMP is currently preparing a guideline on this topic. This meeting aim
01/11/2012
EFSPI/Subgroup Analysis
01/09/2012
EFSPI/BBS/MSB Modelling & Simulation Sept 2012
01/09/2012
Joint European Statistical Meeting - EFSPI/BBS/MSB - Modelling and Simulation and applications
Basel, Switzerland, 13th September 2012 Modelling and Simulation is a broad area appealing to many quantitative scientists and increasingly applied in clinical drug development. The meeting will include presentations on the role of M&S in drug devel
07/06/2012
Joint European Workshop FMS/EFSPI/DSBS: Benefit-Risk Assessment Methodology Workshop
Malmo, Sweden, 7th June 2012 An increase in the use of quantitative Benefit-Risk Assessment methods has been proposed to aid in the evaluation of new medicinal products by regulatory bodies and reimbursement committees throughout the world. This wor
03/06/2012
EFSPI/FMS/DSBS
18/11/2011
European Statistical Meeting: Advances in the Treatment of Missing Data
Brussels,18 November 2011 The treatment of missing data continues to be a challenge in the analysis of clinical trials, potentially affecting the integrity and validity of trial results if not handled appropriately. This meeting aims to bring togeth
01/11/2011
EFSPI/PSI/PDSM/BMS Advances in the Treatment of Missing Data Nov 2011
18/11/2010
EFSPI-SFdS-B&S Joint European Statistical Meeting
Paris, 18-19 November 2010 The European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmacy and Health Group of the SFdS (???Soci??t?? Fran??aise de Statistique???, French Society for Statistics) held their joint on
24/06/2010
Joint EFSPI-BBS meeting, Basel, 24th June 2010 European Statistical Meeting on Oncology
The meeting was aimed at statisticians who have an interest in Oncology or wish to gain a greater understanding.
20/06/2010
EFSPI BBS Oncology 2010
01/05/2010
Joint EFSPI-MHRA meeting - Statistics at the frontier of drug development
The meeting intended to provide a unique opportunity for discussion amongst industry, regulatory and academic scientists.
29/03/2010
EFSPI MHRA 2010
01/01/2010
EFSPI SFdS-B&S 2010
01/06/2009
European Statistical Meeting on Meta Analysis
This meeting was a joint venture between EFSPI and BBS
20/11/2008
European Statistical Meeting on Non-Inferiority
Verona, Italy, November 20th 2008 This meeting was a joint venture between EFSPI, BIAS and SSFA. Non-inferiority trials have been around for many years, but are still controversial. Experts from industry, academia and regulatory bodies have present
01/06/2008
Joint PSI-EFSPI Conference
Brussels, May 18th-21st, 2008 | This was a European Conference aimed at Statisticians in the Pharmaceutical Industry. Many opinion leaders from industry, academia and regulatory have spoken. The conference contained many parallel sessions to provide
01/06/2007
Joint EFSPI/BBS Meeting on Adaptive Designs in Drug Development, Basel
June 15th 2007
01/12/2006
EFSPI Scientific Meeting on Adaptive Randomisation - Today and Tomorrow
December 7th 2006
01/05/2003
EFSPI session at annual PSI Conference, Bristol
01/09/2002
3rd International Workshop on Statistical Methodology in Non-Clinical R&D
Barcelona September 2002
02/10/2001
Henry Stewart briefing: Coping with the Conflicting Requirements for Control
London October 2001
20/08/2000
2nd International Workshop on Statistical Methodology in Non-Clinical R&D
Montreux September 2000
25/10/1999
DIA Workshop on New ICH Guideline on Choice of Control Group in Clinical Trials
The Key Statistical Issues | Brussels November 1999
10/07/1999
ISI 52th session in Helsinki, incl. EFSPI presentations
Helsinki August 1999
31/10/1998
1st International Workshop on Statistical Methodology in Non-Clinical R&D
Nice November 1998
20/09/1997
DIA Workshop on New ICH Guideline on Statistical Principles for Clinical Trials
Nice October 1997
10/03/1996
DIA Workshop on Statistical Methodology in Clinical Research & Development
Copenhagen April 1996
14/02/1996
DIA Workshop on Statistical Methodology in Non-Clinical & Toxicological Studies
Bruges March 1996
15/05/1994
Presentation on Annual DIA Meeting
Washington DC June 1994
22/03/1994
DIA Workshop on A European concept for Good Statistical Practice in Global Drug Development
Edinburgh April 1994
17/09/1993
DIA Forum on European Biostatistics Guidelines
London October 1993
01/07/1993
Presentation on ISI 49th session in Florence
Florence August 1993
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##